Copyright Reports & Markets. All rights reserved.

Global Xerostomia Treatments Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Xerostomia Treatments Market Overview

    • 1.1 Product Overview and Scope of Xerostomia Treatments
    • 1.2 Classification of Xerostomia Treatments by Types
      • 1.2.1 Global Xerostomia Treatments Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Xerostomia Treatments Revenue Market Share by Types in 2018
      • 1.2.3 Salivary Stimulants
      • 1.2.4 Salivary Substitutes
      • 1.2.5 Dentifrices
    • 1.3 Global Xerostomia Treatments Market by Application
      • 1.3.1 Global Xerostomia Treatments Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital Pharmacies
      • 1.3.3 Online Pharmacies
      • 1.3.4 Retail Pharmacies
    • 1.4 Global Xerostomia Treatments Market by Regions
      • 1.4.1 Global Xerostomia Treatments Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Xerostomia Treatments Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Xerostomia Treatments Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Xerostomia Treatments Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Xerostomia Treatments Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Xerostomia Treatments Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Xerostomia Treatments (2014-2024)

    2 Manufacturers Profiles

    • 2.1 GlaxoSmithKline
      • 2.1.1 Business Overview
      • 2.1.2 Xerostomia Treatments Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GlaxoSmithKline Xerostomia Treatments Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Church and Dwight
      • 2.2.1 Business Overview
      • 2.2.2 Xerostomia Treatments Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Church and Dwight Xerostomia Treatments Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Hikma Pharmaceuticals
      • 2.3.1 Business Overview
      • 2.3.2 Xerostomia Treatments Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Hikma Pharmaceuticals Xerostomia Treatments Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Pendopharm
      • 2.4.1 Business Overview
      • 2.4.2 Xerostomia Treatments Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Pendopharm Xerostomia Treatments Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Parnell Pharmaceuticals
      • 2.5.1 Business Overview
      • 2.5.2 Xerostomia Treatments Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Parnell Pharmaceuticals Xerostomia Treatments Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Orahealth
      • 2.6.1 Business Overview
      • 2.6.2 Xerostomia Treatments Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Orahealth Xerostomia Treatments Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Xerostomia Treatments Market Competition, by Players

    • 3.1 Global Xerostomia Treatments Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Xerostomia Treatments Players Market Share
      • 3.2.2 Top 10 Xerostomia Treatments Players Market Share
    • 3.3 Market Competition Trend

    4 Global Xerostomia Treatments Market Size by Regions

    • 4.1 Global Xerostomia Treatments Revenue and Market Share by Regions
    • 4.2 North America Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 4.5 South America Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Xerostomia Treatments Revenue and Growth Rate (2014-2019)

    5 North America Xerostomia Treatments Revenue by Countries

    • 5.1 North America Xerostomia Treatments Revenue by Countries (2014-2019)
    • 5.2 USA Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Xerostomia Treatments Revenue and Growth Rate (2014-2019)

    6 Europe Xerostomia Treatments Revenue by Countries

    • 6.1 Europe Xerostomia Treatments Revenue by Countries (2014-2019)
    • 6.2 Germany Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 6.3 UK Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 6.4 France Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Xerostomia Treatments Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Xerostomia Treatments Revenue by Countries

    • 7.1 Asia-Pacific Xerostomia Treatments Revenue by Countries (2014-2019)
    • 7.2 China Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 7.5 India Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Xerostomia Treatments Revenue and Growth Rate (2014-2019)

    8 South America Xerostomia Treatments Revenue by Countries

    • 8.1 South America Xerostomia Treatments Revenue by Countries (2014-2019)
    • 8.2 Brazil Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Xerostomia Treatments Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Xerostomia Treatments by Countries

    • 9.1 Middle East and Africa Xerostomia Treatments Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Xerostomia Treatments Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Xerostomia Treatments Revenue and Growth Rate (2014-2019)

    10 Global Xerostomia Treatments Market Segment by Type

    • 10.1 Global Xerostomia Treatments Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Xerostomia Treatments Market Forecast by Type (2019-2024)
    • 10.3 Salivary Stimulants Revenue Growth Rate (2014-2024)
    • 10.4 Salivary Substitutes Revenue Growth Rate (2014-2024)
    • 10.5 Dentifrices Revenue Growth Rate (2014-2024)

    11 Global Xerostomia Treatments Market Segment by Application

    • 11.1 Global Xerostomia Treatments Revenue Market Share by Application (2014-2019)
    • 11.2 Xerostomia Treatments Market Forecast by Application (2019-2024)
    • 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
    • 11.4 Online Pharmacies Revenue Growth (2014-2019)
    • 11.5 Retail Pharmacies Revenue Growth (2014-2019)

    12 Global Xerostomia Treatments Market Size Forecast (2019-2024)

    • 12.1 Global Xerostomia Treatments Market Size Forecast (2019-2024)
    • 12.2 Global Xerostomia Treatments Market Forecast by Regions (2019-2024)
    • 12.3 North America Xerostomia Treatments Revenue Market Forecast (2019-2024)
    • 12.4 Europe Xerostomia Treatments Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Xerostomia Treatments Revenue Market Forecast (2019-2024)
    • 12.6 South America Xerostomia Treatments Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Xerostomia Treatments Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Dry mouth (xerostomia) refers to a condition in which the salivary glands in your mouth don't make enough saliva to keep your mouth wet.

      Scope of the Report:
      The global Xerostomia Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Xerostomia Treatments.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Xerostomia Treatments market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Xerostomia Treatments market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      GlaxoSmithKline
      Church and Dwight
      Hikma Pharmaceuticals
      Pendopharm
      Parnell Pharmaceuticals
      Orahealth

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Salivary Stimulants
      Salivary Substitutes
      Dentifrices

      Market Segment by Applications, can be divided into
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      Buy now